Conditions: Kidney Transplantation
Keywords: Kidney Transplantation Mycophenolic Acid Immunosuppression Cyclosporine
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 10

Brief summary:
The study will evaluate kidney graft function in maintenance renal transplant patients.

Detailed description:

Arms:
arm 1: The administration of gradual dose increased to reach 1440 mg/day (V4) of enteric-coated mycophenolate sodium (Myfortic®, EC-MPS) with simultaneous dose reduction of micro emulsion cyclosporine (Neoral®, CsA-ME) given to maintenance kidney transplant patients previously treated with reduced-dose mycophenolate mofetil (MMF) and standard dose CsA-ME arm 2: Patients received unchanged dose of Myfortic® (equimolar to the prior established dose MMF) and unchanged standard dose of CsA-ME.

Interventions: intervention 1: Enteric coated mycophenolate sodium (Myfortic®)
Intervention descriptions: intervention 1: None

Protocol document: